Ginkgo Bioworks Holdings, Inc.
Price Action
Technical Summary
WEAKENINGGinkgo Bioworks Holdings, Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is moderate (RS Rating: 67), indicating performance broadly in line with the market. Earnings growth of 31% provides fundamental context to the price action. However, price is extended 37% above the 50-day line, increasing the risk of a mean reversion.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $8.11 | +24.23% | ABOVE |
| 50 SMA | $7.37 | +36.84% | ABOVE |
| 100 SMA | $8.24 | +22.30% | ABOVE |
| 150 SMA | $9.29 | +8.53% | ABOVE |
| 200 SMA | $10.04 | +0.41% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is DNA in an uptrend right now?
DNA has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is DNA overbought or oversold?
DNA's RSI (14) is 68. The stock is in neutral territory, neither overbought nor oversold.
Is DNA outperforming the market?
DNA has a Relative Strength (RS) Rating of 67 out of 99. DNA is performing about average compared to the market.
Where is DNA in its 52-week range?
DNA is trading at $10.08, which is 57% of its 52-week high ($17.58) and 39% above its 52-week low ($5.37).
How volatile is DNA?
DNA has a Beta of 3.42 and 52-week volatility of 99%. It's more volatile than the S&P 500 - expect bigger swings.